Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GTHP can find a different subcontractor in China -- that's what SMI is.
A Chinese subcontractor that actually has some money.
SMI paid $330,000 according to the 10-K and that's more than I thought they would pay. I wouldn't expect a PR for that extra $100,000 since there wasn't a PR for the $330,000 -- if SMI submits the application to the NMPA in second quarter as promised, there will be a PR then, I believe. And if they don't and the application to the NMPA never gets submitted, worst case scenario, that Chinese clinical trial with 400 patients will help Guided get FDA approval.
So I'm just not feeling the FUD that you and the other FUDster are selling. The Brothers Fudd. Which one is Elmer?
Have a FUD-filled weekend. Perhaps a nice vinegar pie would hit the spot.
Because they finished the Chinese clinical trial and have the endorsement of Chinese gynecologists.
Retracting your assertion of non-disclosure is like saying you're sorry after damaging someone's property. That doesn't repair the damage. The company can sue you for libel.
You're a lawyer. You know that.
They have to dilute to raise Shareholder Equity to avoid delisting, correct?
But how will they satisfy the $1 minimum bid price requirement? That seems like a bigger problem. They tried pretty hard to pump it up over $1 but it just didn't work. Dilution won't fix the Minimum Bid Price problem.
From the 10-K:
I saw that the judge threw out GIUL's conspiracy claims. Tell us what you know about that.
https://masslawyersweekly.com/files/2024/03/09-024-24.pdf
Up 30,000 % today! woo hoo!
gotta admit, that looks good on paper.
the BIEL pumper longs already own WAY too much BIEL.
They are done averaging down. It's up to the company to create new interest in this stock.
"Pink Limited" tickers are not very attractive. True, the gamblers who chase merger rumors like to pump-and-dump shells and Chinese scams (just look at what the Shartmaster is pumping), and THEY don't care whether a ticker is pink limited or not, but BIEL is not a merger play so it's not sexy.
BIEL is stuck in the mud. Maybe something will happen, maybe nothing concrete will ever happen, but this company is never going to file for BK and never going to throw in the towel. Staelin is not going to walk away from his goldmine here, IMO. He knows how much he can make on the Whelan 50% Dilution Scheme -- he got rich dumping a billion shares in the glory days before the SEC poked their nose into it.
It's going to require a reverse split to cash out his existing convertible debt, and then he will likely restructure his non-convertible loans into convertible loans to cash out the rest, but that old fox will get his money back, eventually. It's not like he owes the Whelans anything -- Andy fired his son Adam, after all.
It's so boring, though, waiting for them to fire up their engines. C'mon, Whelan and Staelin, grow a pair and get on with it. I want to read the breathless prose of a
Staelin Pump PR.
I just posted the link to the agreement -- and it was FREE.
That agreement has been in black-and-white for GTHP investors to see for quite some time. It is already DISCLOSED so you can stop posting your libelous statements, please and thank you.
I fail to see this agreement as a negative for GTHP investors. Shenghuo only gets money if SMI pays money. More important, without that agreement there would have been no SMI and there would be no Chinese clinical trials completed, because obviously Shenghuo wasn't going to accomplish anything in China.
The REAL value here is in the FDA approval. That's going to take awhile but I'm quite confident that this time the FDA will approve the device. FDA approval has nothing to do with your lawsuit and it has nothing to do with Shenghuo. If SMI pays any money, that will be icing on the cake (they already paid $330,000), but even if they don't pay any more money, they already accomplished a valuable feat: Chinese clinical trials were completed without costing Guided a lot of money, and the submission to the Chinese FDA can now happen whether SMI does it or not.
That has nothing to do with Guided Therapeutics and is therefore off topic.
I don't believe you because one of these must be true:
* You are lying and therefore guilty of libel;
OR
* You are disclosing insider information and that is illegal.
Either way -- why should anyone trust you?
I believe the first bullet above describes the situation. The agreement to which you refer is disclosed in the financial statement as Exhibit 10.13, which makes YOU guilty of libel. Here is Exhibit 10.13 from the 10-K:
https://content.edgar-online.com/ExternalLink/EDGAR/0001121781-17-000006.html?hash=4440d5c8e862c59bf3763cf92d5c1b90ff360893e0a6c1f7044372876f5bc32a&dest=ex10two_htm#ex10two_htm
That would be swell.
Again, I'm just saying, SOMEBODY needs to take care of the little things, like filing the annual report in Nevada. And there are a lot of missing financial reports -- Currier never did get OTCIQ access, obviously.
Maybe they'll go the SEC reporting route and resume filing with the SEC, the way they did with KATX, but OTCmarkets.com won't give them OTCIQ access if the Corporation isn't Active in Nevada, the state of incorporation.
As for "really soon," maybe, maybe not. A lot of promises and assurances made in the past 2-1/2 years didn't come true. I think something will probably happen someday with LLBO but whoever is in charge (Currier, Acropolis, Ryan Ash, ???) hasn't done a good job so far of moving "really fast." Is that Holmes' fault? Probably -- he was a con man, IMO, may he RIP. But you have to admit that nothing has happened here "really fast."
I don't know why you think she's "very healthy." She stepped down from being CEO of OWUV because of her health. Read this PR from Sept. 2023:
https://www.otcmarkets.com/stock/OWUV/news/FOUNDING-CEO-IS-BACK?id=414085
Whatever. All I'm saying is: SOMEBODY needs to take care of the Corporation status in Nevada.
You realize that SHOSHONI CORPORATE SERVICES is the name Holmes' wife used as the Registered Agent for all of the scam corporations created by Holmes and Benardis? There were at least a dozen. Jimmy was a Busy Bee.
She's not going to lift a finger for Lifeline Biotechnologies now, IMO.
If Currier's health is preventing her from doing anything, somebody else needs to pick up the ball and run with it. First job is to get the Corporation back to ACTIVE in Nevada before the status changes to Revoked, because that's even MORE work to Reinstate a Revoked corporation.
On a positive note, I think the "Advances Payable" described in NOTE 8 on page 13 in the last financial statement (link below) -- the mysterious "payable upon demand" loan -- is gone, if that is the debt owed to the Holmes Family that was recently described as "settled." That was hopefully the one thing preventing an audit.
https://www.otcmarkets.com/otcapi/company/financial-report/227520/content
It doesn't matter who is listed as President. What matters is: the Entity Status is "Default."
Currier stayed on as President or CEO in other companies she worked on. SOMEBODY has to try and find a merger candidate.
One concern is that Currier's health isn't good.
No it says Entity Status Default.
the registered agent, SHOSHONI CORPORATE SERVICES, is Holmes' wife. That status on SilverFlume means nothing.
The Corporation is in Default with the State of Nevada. Somebody needs to get the Corporation status back to Active before they'll be able to do much else with this ticker. I think they just need to file the Annual List, unless they let it go too long in which case they'll get Revoked.
Currier was maintaining the Corporation in Nevada up through 2022 but somebody missed the annual filing in November 2023.
Search for Lifeline Biotech here:
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
The OTC is hot right now for zombie tickers. If LLBO manages to get out of the Expert Market, it will pop.
If they didn't know the OTCIQ rules before, why do you think they know the OTCIQ rules now?
Their PLAN is to process TWO name changes in Nevada within a 45-day period. Seems like that will look MORE suspicious to otcmarkets than ONE name change. But maybe it will work.
In two weeks -- May 1st -- we'll know. Until then, I guess we can watch this site for the name change request in Nevada:
https://esos.nv.gov/EntitySearch/OnlineEntitySearch
The name was officially changed in Nevada. Now they're changing it BACK, according to their website.
They're not cancelling or rescinding the name change -- they're processing another name change. Will OTCmarkets give them access to OTCIQ then? That's a crapshoot. They clearly don't know what they're doing. It took them this long to figure out the problem with OTCIQ access, and that's lame. Maybe they should hire a REAL lawyer or pay an advisor to explain how OTC stocks and FINRA roll in the USA.
The annual report is due in two weeks. I'll buy this if they get the annual report uploaded before 4/30. If they don't, and I'd say the odds are good that they won't, they're going to Expert Market.
KW foregoes all salary for years ending December 31, 2023 / 2022
Paying her what she's worth, IMO.
IBEX LLC agreed to forgo all interest from 2020 through 2023
That's great, since the company can't pay it.
Keith Nalepka still owns 100 million BIEL Shares
What a Trooper. He isn't cashing out his $20,000 worth of BIEL stock. Compared to Staelin who's dumped a billion shares in the past 10 years, he's a BIEL flag-waver.
Dr Staelin supports BIEL with $500k in new loans for 2023
That is good news. Imagine where this company would be if Staelin wasn't willing to keep pouring money into this black hole.
BIEL still investing in R&D $272K
$272k is a lot of money for this company. It's peanuts for a successful company, but BIEL is not a successful company, is it?
Revenue up from 2022
Up $7000 over 2022, when the pandemic, the Chinese port closures, and the chip shortage all hurt sales.... 2023 was $7000 higher. Bonuses all around!
General/Administrative costs down by $80k compared to 2022
$80k is a lot of money for this company. It's peanuts for a successful company, but BIEL is not a successful company, is it?
Sales/Marketing cost lowered by $120k compared to 2022
Yeah we wouldn't want them to spend any money on Sales/Marketing.
"Not bad at all?" Better than I expected, but come on, $714k is bad.
2022 was terrible. The diehards blamed Covid, Chinese port closures, and chip shortages. 2023 revenues show an increase of $7000?
I think their auditor forgot to remove Nalepka's "VP" title at the end.
I'm sorry, am I being negative? Let me change my message to:
Yay. woo hoo. yippee.
(good lord, Staelin lent them a lot of money. WTF is he thinking.)
Do YOU have anything but FUD?
The clinical trials are taking longer than predicted. Do you ever read the filings, or do you just wait for me to explain them to you?
The clinical trials didn't finish in March 2024 as projected. That's the reason for the PPS decline. Accept that, or move on.
Do you know what FUD means?
Fear Uncertainty Doubt.
"This stock is at multi-year low" is a lie.
"In last 7+ years GTHP never saw a green day" is a lie.
"this stock will never see a day when it will close above 0.15$ & stay above 0.15$" is bullshit.
You are the FUD poster child. Congratulations.
Oh come on, I have Art on Ignore and you know it.
Boring shit, this.
but doesn't it bother you that when you read their tweets from the past year, they planned to make a "fresh start" with tattoo lotion, pot, gold, crypto, restaurants, and Jerk Chicken franchises?
All the while diluting with 3 billion new shares?
And all of those "fresh starts" turned out to be just BS?
I'm not seeing why anyone should regard this company's new biotech merger is anything more than the next BS pump in a long line of BS pumps. As I said before, I actually expect a tweet in a few weeks about a huge AI deal.
Maybe I'm wrong, but that 3 billion share increase in the past year looks REALLY ugly on the financial statement when you realize that 3 billion new shares only reduced their debt from 34 million to 33 million.
How much of this hype is P&D artists like shartmaster buying a dead ticker at .0001 and trying to convince their "followers" into buying their stock at .0002?
Am I correct to interpret the current bullish sentiment as believing this:
"the new Chinese owners obtained OTCIQ access?"
If that's the belief -- what is the excuse/reason for not updating anything on otcmarkets.com other than owner names?
Thanks!
No, YOU should take it up with FINRA because YOU are the only one who has a complaint.
Everyone else's "complaint" is about your misinformation and I doubt FINRA wants to hear complaints about an anonymous MB poster spreading bullshit.
FINRA explains how MM's don't have to cover by the end of the day and how FINRA does not consider that to be illegal naked shorting. Some choose to understand and accept that. You don't, fine, your choice.
If the MM's didn't try so hard to make a market here, this stock would barely trade at all. There'd be zero volume days. That would make you happy?
Nobody is shorting BIEL. Nobody shorts a stock under .0003 -- that would be insane.
The REGSHO report shows a failure to cover by the MM's and that's VERY different from shorting.
But you know that, don't you. Your agenda simply prevents you from acknowledging that. You want to depict the evil MM's as single-handedly keeping the BIEL PPS down.
And that's nonsense. The anemic PPS is not the fault of the MM's. The MM's don't care what the PPS is -- they make their money regardless of the PPS. They simply want to create volume.
But the filing is not late. It won't be late until April 30th.
Assuming Whelan wants to remain "Pink Unlimited." And I think that's a safe assumption.
thast's all off topic from my post, but, whatever.
otcmarkets changed their rules for Pink Limited. They extended the deadline by 30 days for Pink Limited, from 90 to 120. The deadline is April 30th, or May 15th if Whelan files another Notification of Late Filing.
So it's not going to Expert Market this month.
I didn't see this rule change (effective 12/31/2023) and neither did Whelan. If she had known, she wouldn't have filed that "Notification of Late Filing" so early.
I don't know when the Attorney Letter is due -- probably also extended 30 days. Not going to bother looking it up.
Meanwhile, Ilfeld's opioid study was supposed to finish last week:
https://clinicaltrials.gov/study/NCT05399355
Took him about six months to publish the results of the phantom pain pilot study, which is quite fast. Maybe he can get the opioid study published by EOY and BIEL can use it to convince the CMS to accept it as proof for NOPAIN reimbursement. NOPAIN is pretty much the only pump going here. Hope he doesn't wait for the SofPulse trial to finish and publish them together.
That's exactly the right attitude! It is just a lotto play and the good news is that there's plenty of interest.
I agree, the "massive debt reduction" is in the past -- I believe they're talking about the massive dilution they did in 2023, especially July 2023 through December, shown on page 6 and 7 of the annual statement:
https://www.otcmarkets.com/otcapi/company/financial-report/395392/content
None of that is a surprise now of course -- it's there in black and white. If they came up with cash somehow to pay down more of their existing debt, that would be good news of course, depending on how they got the cash. Because that annual report shows that they have ZERO cash on hand.
Regardless, best of luck, and if you're not greedy you'll probably do just fine here. I simply moved on to other plays that I like better.
yeah I'm out.
in the past year this company has tweeted about their huge deals regarding tattoo lotion, pot, gold, crypto, restaurants, Jerk Chicken franchises, and now a biotech merger. The whole time they've been posting pictures of Bobby Axelrod and converting loans at 50% by issuing 3 billion shares.
I think the "massive debt reduction" refers to that 3 billion dilution they did in 2023 to knock their massive $34M debt down to.... a massive $33 million.
Their next tweet will probably be about AI. Yeah, that's the ticket, a huge AI acquisition. With another testimonial from Bobby Axelrod.
Best of luck to all who remain.
True, especially when compared to the "reasons" of the pump and dump artist to whom I was initially replying.
Thanks!
yeah, really not bashing, just speaking a simple truth about all of these OTC shell plays.
I know the pump-and-dump artists don't want this truth spoken out loud. That's why I bother.
The R/S is not fake. The new owners will do a reverse split "as soon as possible" in their own words from the amendment they filed with the State of Nevada.
Yes, maybe they will merge some capital into this shell, but they will also do a reverse split. The question is WHEN.
So this is a game of musical chairs. Hopefully, you can sell your shares to "newbies" or to the Shartmaster right before the R/S.
Maybe the PPS won't implode after a R/S. If they file an annual report that shows big $$$ assets and/or big $$$ revenues, maybe the PPS will hold. Occasionally, you see that in OTC.
And there is a chance that FINRA will refuse to process the R/S request, but I don't see that as good news because if FINRA doesn't let them do the R/S they'll abandon the shell. There's no point in merging into a shell and going public if you can't use the shell to raise capital. They're not going to just give stock and dividends to a bunch of existing shareholders from a pinkie scam weed ticker.
Of COURSE they will do a R/S. If they're smart they'll call this ticker a subsidiary of the Chinese parent company and do the R/S before they transfer in assets. If they're stupid, they'll transfer in assets BEFORE... but why would anyone want to invest in a company run by stupid people?
That's rhetorical of course. Nobody wants to INVEST in this ticker -- it's a pinkie OTC reverse merger and everyone wants to trade it and get out before the R/S. Some will succeed. Some will be left holding the bag. Best of luck.
You think "Ten Associates" is the lawyer for JFH?
When you keep saying "our lawyer said," you mean TEN ASSOCIATES?
Yes the shareholders go with the sale of the shell.
Personally, I would buy LLBO if I were in Canada just as a lottery ticket, but I'd sell immediately if/when it went to Pink Current because there's always a spike when that happens but then virtually all of these shells turn out to be duds. Look at EVERY Currier merger. They all went to crap soon after the merger. She got HER money and some traders flipped them for a fast profit but everyone who held lost pretty much everything.
Pick one, any one: KATX KAST OWUV KRFG ILST ILUS.......
Did you see that KATX is going to do a reverse split? Assuming FINRA lets them, of course. They probably have to file that missing 10-K first to get back out of Expert Market. But the new owners in these Custodian/Merger plays usually do a reverse split soon after buying the shell because the whole purpose of buying a shell and going public is to get funding by selling stock.
Hope LLBO works out for you and the rest of the Longs. What you want to see are some Twitter crooks pumping it with lies about mergers if/when it gets Current. Sell that pump if you see it.